Abbott
Automatic glucose monitoring system gets NHS approval
A system designed to automatically measure glucose levels through a sensor has been approved by the NHS and will be available for reimbursement across England, Wales, Scotland and Northern Ireland from 1 November. more
13 Sep 2017 15:40 News
Medical Plastics News: Weekly news roundup
Medical Plastics News takes a look at some of the biggest stories that have emerged over the past week. more
4 Sep 2017 16:05 News
Abbott pacemakers recalled over cyber-security vulnerabilities
Over 500,000 pacemakers developed by medical device maker Abbott have been shown to contain cyber-security issues. more
31 Aug 2017 10:25 Devices
Abbott’s smartphone compatible cardiac monitor gains CE Mark approval
Healthcare company Abbott has announced that its smartphone compatible Confirm Insertable Cardiac Monitor (ICM) has gained CE Mark approval. more
9 May 2017 11:45 Devices
Abbott responds to FDA warning letter
The Food and Drug Administration (FDA) has warned medical device maker Abbott that it must submit a plan to address any cybersecurity issues and other safety issues identified in cardiac devices from the company’s recently acquired St Jude Medical. more
21 Apr 2017 10:00 News
Abbott hunts for employees
Abbott is aiming to recruit more than 150 people to work at its UK diabetes care manufacturing hub in Witney, Oxfordshire more
6 May 2016 15:58 News
Dissolving heart stent gets FDA thumbs up
The US Food and Drug Administration (FDA) Advisory Committee gives Abbott’s fully dissolving heart stent a positive review and recommends the FDA approve it more
17 Mar 2016 10:46 News
Absorbable stents non-inferior to metal, study finds
A drug-eluting coronary stent made of a biodegradable polymer performed similarly to the gold-standard metal one in a non-inferiority trial among patients with the more serious type of heart attack known as ST-segment elevation myocardial infarction more
19 Nov 2015 17:00 News
Positive clinical trial results for dissolving heart stent
Abbott has announced positive one-year clinical results from the Absorb III trial more
19 Oct 2015 14:49 News
Event: Diabetes Professional Care 2015
Diabetes Professional Care 2015 will take place at the Barbican Exhibition Centre in London from 11-12 November more
7 Oct 2015 10:05 News
Abbott completes acquisition of Topera
Done deal: Abbott has completed its acquisition of Topera, a medical device company focused on developing innovative electrophysiology technologies more
23 Dec 2014 10:39 News
Roche and LifeScan among strongest players in glucose monitoring devices market in Benelux and Scandinavia
In the lead: The growing market for glucose monitoring devices in Benelux and Scandinavian countries is currently led by Roche more
6 Jul 2014 17:33 News
Source: St Jude Medical.
Minimally Invasive Device Industry Newsround
Technologies for minimally invasive devices are a fast developing area. As tubes get smaller, thinner and stronger, surgeons are expected to be able to access areas of the body with more accuracy and less pain for the patient. more
22 Jul 2013 08:00 Devices
Asia Roundup, Q2 2013: Japan, China, South Korea, Singapore and Thailand
BASF's announcement of a €10 bn investment over seven years in Asia will stimulate much activity in the region, especially in plastics. Clinical trials of Abbott's Absorb stent in Japan are influential too. more
2 Jul 2013 00:00 News
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
Abbott (NYSE: ABT) today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c (HbA1c) test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for develop more
9 May 2013 00:00 News
Abbott Publish Data on Clinical Performance of Absorb Bioresorbable Stent
US headquartered healthcare product manufacturer Abbott has published data which the company says supports the long-term performance of its Absorb bioresorbable vascular stent. more
15 Mar 2013 00:00 Devices
US Clinical Trials Begin for Abbott's Remarkable Resorbable Stent
US-headquartered device manufacturer Abbott announced today the initiation of the Absorb III clinical trial in patients in the United States. more
8 Jan 2013 00:00 Devices